News for 4D pharma plc (4DY.F)

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated?Top 50?in the 2018 and 2019 ISS... | February 27, 2021

NEW YORK, Feb. 26, 2021 /PRNewswire/ --Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rat...

/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS...

NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated  Top

CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors GlobeNewswire February 24, 2021 DURHAM, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical stage immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the appointment of Dr. Edgardo Baracchini,...

4D pharma plc , a pharmaceutical company leading the development of Live Biotherapeutic products , a novel class of drug derived from the microbiome, today announced a clinical trial collaboration... | February 8, 2021

Home Press releases 4D pharma announces clinical trial collaboration with Merck KGaA and Pfizer to evaluate MRx0518 in combination with... | February 8, 2021

WILMINGTON, Del., Jan. 07, 2021 -- Rigrodsky & Long, P.A. announces that it is investigating: Sunesis Pharmaceuticals, Inc. regarding possible breaches of fiduciary duties and other...